Global and United States CAR T-Cell Therapy Market Report & Forecast 2022-2028

Publisher Name :
Date: 20-Jun-2022
No. of pages: 103
Inquire Before Buying

CAR T-Cell Therapy market is segmented by region (country), players, by Type and by Application. Players, stakeholders, and other participants in the global CAR T-Cell Therapy market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by region (country), by Type and by Application for the period 2017-2028.

For United States market, this report focuses on the CAR T-Cell Therapy market size by players, by Type and by Application, for the period 2017-2028. The key players include the global and local players, which play important roles in United States.

Segment by Type

- Allogeneic

- Autologous

Segment by Application

- Hospitals

- Cancer Research Centers

- Others

By Region

- North America

- - U.S.

- - Canada

- Europe

- - Germany

- - France

- - U.K.

- - Italy

- - Russia

- Asia-Pacific

- - China

- - Japan

- - South Korea

- - India

- - Australia

- - Taiwan

- - Indonesia

- - Thailand

- - Malaysia

- - Philippines

- - Vietnam

- Latin America

- - Mexico

- - Brazil

- - Argentina

- Middle East & Africa

- - Turkey

- - Saudi Arabia

- - U.A.E

By Company

- Celgene (Juno Therapeutics)

- Novartis

- Gilead (Kite Pharma)

- Pfizer

- CARsgen Therapeutics

- Autolus Therapeutics

- Aurora BioPharma

- Sorrento Therapeutics

- Mustang Bio

- Bluebird Bio

- Collectis

- Allogene Therapeutics

- Celyad

Global and United States CAR T-Cell Therapy Market Report & Forecast 2022-2028

Table of Contents
1 Study Coverage
1.1 CAR T-Cell Therapy Revenue in CAR T-Cell Therapy Business (2017-2022) & (US$ Million) Introduction
1.2 Global CAR T-Cell Therapy Outlook 2017 VS 2022 VS 2028
1.2.1 Global CAR T-Cell Therapy Market Size for the Year 2017-2028
1.2.2 Global CAR T-Cell Therapy Market Size for the Year 2017-2028
1.3 CAR T-Cell Therapy Market Size, United States VS Global, 2017 VS 2022 VS 2028
1.3.1 The Market Share of United States CAR T-Cell Therapy in Global, 2017 VS 2022 VS 2028
1.3.2 The Growth Rate of CAR T-Cell Therapy Market Size, United States VS Global, 2017 VS 2022 VS 2028
1.4 CAR T-Cell Therapy Market Dynamics
1.4.1 CAR T-Cell Therapy Industry Trends
1.4.2 CAR T-Cell Therapy Market Drivers
1.4.3 CAR T-Cell Therapy Market Challenges
1.4.4 CAR T-Cell Therapy Market Restraints
1.5 Study Objectives
1.6 Years Considered
2 CAR T-Cell Therapy by Type
2.1 CAR T-Cell Therapy Market Segment by Type
2.1.1 Allogeneic
2.1.2 Autologous
2.2 Global CAR T-Cell Therapy Market Size by Type (2017, 2022 & 2028)
2.3 Global CAR T-Cell Therapy Market Size by Type (2017-2028)
2.4 United States CAR T-Cell Therapy Market Size by Type (2017, 2022 & 2028)
2.5 United States CAR T-Cell Therapy Market Size by Type (2017-2028)
3 CAR T-Cell Therapy by Application
3.1 CAR T-Cell Therapy Market Segment by Application
3.1.1 Hospitals
3.1.2 Cancer Research Centers
3.1.3 Others
3.2 Global CAR T-Cell Therapy Market Size by Application (2017, 2022 & 2028)
3.3 Global CAR T-Cell Therapy Market Size by Application (2017-2028)
3.4 United States CAR T-Cell Therapy Market Size by Application (2017, 2022 & 2028)
3.5 United States CAR T-Cell Therapy Market Size by Application (2017-2028)
4 Global CAR T-Cell Therapy Competitor Landscape by Company
4.1 Global CAR T-Cell Therapy Market Size by Company
4.1.1 Top Global CAR T-Cell Therapy Companies Ranked by Revenue (2021)
4.1.2 Global CAR T-Cell Therapy Revenue by Player (2017-2022)
4.2 Global CAR T-Cell Therapy Concentration Ratio (CR)
4.2.1 CAR T-Cell Therapy Market Concentration Ratio (CR) (2017-2022)
4.2.2 Global Top 5 and Top 10 Largest Companies of CAR T-Cell Therapy in 2021
4.2.3 Global CAR T-Cell Therapy Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
4.3 Global CAR T-Cell Therapy Headquarters, Revenue in CAR T-Cell Therapy Business (2017-2022) & (US$ Million) Type
4.3.1 Global CAR T-Cell Therapy Headquarters and Area Served
4.3.2 Global CAR T-Cell Therapy Companies Revenue in CAR T-Cell Therapy Business (2017-2022) & (US$ Million) Type
4.3.3 Date of International Companies Enter into CAR T-Cell Therapy Market
4.4 Companies Mergers & Acquisitions, Expansion Plans
4.5 United States CAR T-Cell Therapy Market Size by Company
4.5.1 Top CAR T-Cell Therapy Players in United States, Ranked by Revenue (2021)
4.5.2 United States CAR T-Cell Therapy Revenue by Players (2020, 2021 & 2022)
5 Global CAR T-Cell Therapy Market Size by Region
5.1 Global CAR T-Cell Therapy Market Size by Region: 2017 VS 2022 VS 2028
5.2 Global CAR T-Cell Therapy Market Size by Region (2017-2028)
5.2.1 Global CAR T-Cell Therapy Market Size by Region: 2017-2022
5.2.2 Global CAR T-Cell Therapy Market Size by Region (2023-2028)
6 Segment in Region Level & Country Level
6.1 North America
6.1.1 North America CAR T-Cell Therapy Market Size YoY Growth 2017-2028
6.1.2 North America CAR T-Cell Therapy Market Facts & Figures by Country (2017, 2022 & 2028)
6.1.3 U.S.
6.1.4 Canada
6.2 Asia-Pacific
6.2.1 Asia-Pacific CAR T-Cell Therapy Market Size YoY Growth 2017-2028
6.2.2 Asia-Pacific CAR T-Cell Therapy Market Facts & Figures by Region (2017, 2022 & 2028)
6.2.3 China
6.2.4 Japan
6.2.5 South Korea
6.2.6 India
6.2.7 Australia
6.2.8 Taiwan
6.2.9 Indonesia
6.2.10 Thailand
6.2.11 Malaysia
6.2.12 Philippines
6.3 Europe
6.3.1 Europe CAR T-Cell Therapy Market Size YoY Growth 2017-2028
6.3.2 Europe CAR T-Cell Therapy Market Facts & Figures by Country (2017, 2022 & 2028)
6.3.3 Germany
6.3.4 France
6.3.5 U.K.
6.3.6 Italy
6.3.7 Russia
6.4 Latin America
6.4.1 Latin America CAR T-Cell Therapy Market Size YoY Growth 2017-2028
6.4.2 Latin America CAR T-Cell Therapy Market Facts & Figures by Country (2017, 2022 & 2028)
6.4.3 Mexico
6.4.4 Brazil
6.4.5 Argentina
6.5 Middle East and Africa
6.5.1 Middle East and Africa CAR T-Cell Therapy Market Size YoY Growth 2017-2028
6.5.2 Middle East and Africa CAR T-Cell Therapy Market Facts & Figures by Country (2017, 2022 & 2028)
6.5.3 Turkey
6.5.4 Saudi Arabia
6.5.5 U.A.E
7 Company Profiles
7.1 Celgene (Juno Therapeutics)
7.1.1 Celgene (Juno Therapeutics) Company Details
7.1.2 Celgene (Juno Therapeutics) Business Overview
7.1.3 Celgene (Juno Therapeutics) CAR T-Cell Therapy Introduction
7.1.4 Celgene (Juno Therapeutics) Revenue in CAR T-Cell Therapy Business (2017-2022)
7.1.5 Celgene (Juno Therapeutics) Recent Development
7.2 Novartis
7.2.1 Novartis Company Details
7.2.2 Novartis Business Overview
7.2.3 Novartis CAR T-Cell Therapy Introduction
7.2.4 Novartis Revenue in CAR T-Cell Therapy Business (2017-2022)
7.2.5 Novartis Recent Development
7.3 Gilead (Kite Pharma)
7.3.1 Gilead (Kite Pharma) Company Details
7.3.2 Gilead (Kite Pharma) Business Overview
7.3.3 Gilead (Kite Pharma) CAR T-Cell Therapy Introduction
7.3.4 Gilead (Kite Pharma) Revenue in CAR T-Cell Therapy Business (2017-2022)
7.3.5 Gilead (Kite Pharma) Recent Development
7.4 Pfizer
7.4.1 Pfizer Company Details
7.4.2 Pfizer Business Overview
7.4.3 Pfizer CAR T-Cell Therapy Introduction
7.4.4 Pfizer Revenue in CAR T-Cell Therapy Business (2017-2022)
7.4.5 Pfizer Recent Development
7.5 CARsgen Therapeutics
7.5.1 CARsgen Therapeutics Company Details
7.5.2 CARsgen Therapeutics Business Overview
7.5.3 CARsgen Therapeutics CAR T-Cell Therapy Introduction
7.5.4 CARsgen Therapeutics Revenue in CAR T-Cell Therapy Business (2017-2022)
7.5.5 CARsgen Therapeutics Recent Development
7.6 Autolus Therapeutics
7.6.1 Autolus Therapeutics Company Details
7.6.2 Autolus Therapeutics Business Overview
7.6.3 Autolus Therapeutics CAR T-Cell Therapy Introduction
7.6.4 Autolus Therapeutics Revenue in CAR T-Cell Therapy Business (2017-2022)
7.6.5 Autolus Therapeutics Recent Development
7.7 Aurora BioPharma
7.7.1 Aurora BioPharma Company Details
7.7.2 Aurora BioPharma Business Overview
7.7.3 Aurora BioPharma CAR T-Cell Therapy Introduction
7.7.4 Aurora BioPharma Revenue in CAR T-Cell Therapy Business (2017-2022)
7.7.5 Aurora BioPharma Recent Development
7.8 Sorrento Therapeutics
7.8.1 Sorrento Therapeutics Company Details
7.8.2 Sorrento Therapeutics Business Overview
7.8.3 Sorrento Therapeutics CAR T-Cell Therapy Introduction
7.8.4 Sorrento Therapeutics Revenue in CAR T-Cell Therapy Business (2017-2022)
7.8.5 Sorrento Therapeutics Recent Development
7.9 Mustang Bio
7.9.1 Mustang Bio Company Details
7.9.2 Mustang Bio Business Overview
7.9.3 Mustang Bio CAR T-Cell Therapy Introduction
7.9.4 Mustang Bio Revenue in CAR T-Cell Therapy Business (2017-2022)
7.9.5 Mustang Bio Recent Development
7.10 Bluebird Bio
7.10.1 Bluebird Bio Company Details
7.10.2 Bluebird Bio Business Overview
7.10.3 Bluebird Bio CAR T-Cell Therapy Introduction
7.10.4 Bluebird Bio Revenue in CAR T-Cell Therapy Business (2017-2022)
7.10.5 Bluebird Bio Recent Development
7.11 Collectis
7.11.1 Collectis Company Details
7.11.2 Collectis Business Overview
7.11.3 Collectis CAR T-Cell Therapy Introduction
7.11.4 Collectis Revenue in CAR T-Cell Therapy Business (2017-2022)
7.11.5 Collectis Recent Development
7.12 Allogene Therapeutics
7.12.1 Allogene Therapeutics Company Details
7.12.2 Allogene Therapeutics Business Overview
7.12.3 Allogene Therapeutics CAR T-Cell Therapy Introduction
7.12.4 Allogene Therapeutics Revenue in CAR T-Cell Therapy Business (2017-2022)
7.12.5 Allogene Therapeutics Recent Development
7.13 Celyad
7.13.1 Celyad Company Details
7.13.2 Celyad Business Overview
7.13.3 Celyad CAR T-Cell Therapy Introduction
7.13.4 Celyad Revenue in CAR T-Cell Therapy Business (2017-2022)
7.13.5 Celyad Recent Development
8 Research Findings and Conclusion
9 Appendix
9.1 Research Methodology
9.1.1 Methodology/Research Approach
9.1.2 Data Source
9.2 Author Details
9.3 Disclaimer
List of Tables
Table 1. CAR T-Cell Therapy Market Size United States VS Global, CAGR (2017 VS 2022 VS 2028)
Table 2. CAR T-Cell Therapy Market Trends
Table 3. CAR T-Cell Therapy Market Drivers
Table 4. CAR T-Cell Therapy Market Challenges
Table 5. CAR T-Cell Therapy Market Restraints
Table 6. Global CAR T-Cell Therapy Market Size by Type: 2017 VS 2022 VS 2028 (US$ Million)
Table 7. United States CAR T-Cell Therapy Market Size by Type: 2017 VS 2022 VS 2028 (US$ Million)
Table 8. Global CAR T-Cell Therapy Market Size by Application: 2017 VS 2022 VS 2028 (US$ Million)
Table 9. United States CAR T-Cell Therapy Market Size by Application: 2017 VS 2022 VS 2028 (US$ Million)
Table 10. Top CAR T-Cell Therapy Companies in Global Market, Ranking by Revenue (2021)
Table 11. Global CAR T-Cell Therapy Revenue by Player, (US$ Million), 2017-2022
Table 12. Global CAR T-Cell Therapy Revenue Share by Player, 2017-2022
Table 13. Global CAR T-Cell Therapy Companies Market Concentration Ratio (CR5 and HHI)
Table 14. Global CAR T-Cell Therapy by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in CAR T-Cell Therapy as of 2021)
Table 15. Top Players of CAR T-Cell Therapy in Global Market, Headquarters and Area Served
Table 16. Companies Revenue in CAR T-Cell Therapy Business (2017-2022) & (US$ Million) Type
Table 17. Date of International Companies Enter into CAR T-Cell Therapy Market
Table 18. Companies Mergers & Acquisitions, Expansion Plans
Table 19. Top CAR T-Cell Therapy Players in United States Market, Ranking by Revenue (2021)
Table 20. United States CAR T-Cell Therapy Revenue by Players, (US$ Million), 2020, 2021 & 2022
Table 21. United States CAR T-Cell Therapy Revenue Share by Players, 2020, 2021 & 2022
Table 22. Global CAR T-Cell Therapy Market Size by Region (US$ Million): 2017 VS 2022 VS 2028
Table 23. Global CAR T-Cell Therapy Market Size by Region (2017-2022) & (US$ Million)
Table 24. Global CAR T-Cell Therapy Market Size Forecast by Region (2023-2028) & (US$ Million)
Table 25. North America CAR T-Cell Therapy Sales in Value by Country (2017-2028) & (US$ Million)
Table 26. Asia Pacific CAR T-Cell Therapy Sales in Value by Region (2017-2028) & (US$ Million)
Table 27. Europe CAR T-Cell Therapy Sales in Value by Country (2017-2028) & (US$ Million)
Table 28. Latin Americaa CAR T-Cell Therapy Sales in Value by Country (2017-2028) & (US$ Million)
Table 29. Middle East and Africa CAR T-Cell Therapy Sales in Value by Country (2017-2028) & (US$ Million)
Table 30. Celgene (Juno Therapeutics) Company Details
Table 31. Celgene (Juno Therapeutics) Business Overview
Table 32. Celgene (Juno Therapeutics) CAR T-Cell Therapy Product
Table 33. Celgene (Juno Therapeutics) Revenue in CAR T-Cell Therapy Business (2017-2022) & (US$ Million)
Table 34. Celgene (Juno Therapeutics) Recent Development
Table 35. Novartis Company Details
Table 36. Novartis Business Overview
Table 37. Novartis CAR T-Cell Therapy Product
Table 38. Novartis Revenue in CAR T-Cell Therapy Business (2017-2022) & (US$ Million)
Table 39. Novartis Recent Development
Table 40. Gilead (Kite Pharma) Company Details
Table 41. Gilead (Kite Pharma) Business Overview
Table 42. Gilead (Kite Pharma) CAR T-Cell Therapy Product
Table 43. Gilead (Kite Pharma) Revenue in CAR T-Cell Therapy Business (2017-2022) & (US$ Million)
Table 44. Gilead (Kite Pharma) Recent Development
Table 45. Pfizer Company Details
Table 46. Pfizer Business Overview
Table 47. Pfizer CAR T-Cell Therapy Product
Table 48. Pfizer Revenue in CAR T-Cell Therapy Business (2017-2022) & (US$ Million)
Table 49. Pfizer Recent Development
Table 50. CARsgen Therapeutics Company Details
Table 51. CARsgen Therapeutics Business Overview
Table 52. CARsgen Therapeutics CAR T-Cell Therapy Product
Table 53. CARsgen Therapeutics Revenue in CAR T-Cell Therapy Business (2017-2022) & (US$ Million)
Table 54. CARsgen Therapeutics Recent Development
Table 55. Autolus Therapeutics Company Details
Table 56. Autolus Therapeutics Business Overview
Table 57. Autolus Therapeutics CAR T-Cell Therapy Product
Table 58. Autolus Therapeutics Revenue in CAR T-Cell Therapy Business (2017-2022) & (US$ Million)
Table 59. Autolus Therapeutics Recent Development
Table 60. Aurora BioPharma Company Details
Table 61. Aurora BioPharma Business Overview
Table 62. Aurora BioPharma CAR T-Cell Therapy Product
Table 63. Aurora BioPharma Revenue in CAR T-Cell Therapy Business (2017-2022) & (US$ Million)
Table 64. Aurora BioPharma Recent Development
Table 65. Sorrento Therapeutics Company Details
Table 66. Sorrento Therapeutics Business Overview
Table 67. Sorrento Therapeutics CAR T-Cell Therapy Product
Table 68. Sorrento Therapeutics Revenue in CAR T-Cell Therapy Business (2017-2022) & (US$ Million)
Table 69. Sorrento Therapeutics Recent Development
Table 70. Mustang Bio Company Details
Table 71. Mustang Bio Business Overview
Table 72. Mustang Bio CAR T-Cell Therapy Product
Table 73. Mustang Bio Revenue in CAR T-Cell Therapy Business (2017-2022) & (US$ Million)
Table 74. Mustang Bio Recent Development
Table 75. Bluebird Bio Company Details
Table 76. Bluebird Bio Business Overview
Table 77. Bluebird Bio CAR T-Cell Therapy Product
Table 78. Bluebird Bio Revenue in CAR T-Cell Therapy Business (2017-2022) & (US$ Million)
Table 79. Bluebird Bio Recent Development
Table 80. Collectis Company Details
Table 81. Collectis Business Overview
Table 82. Collectis CAR T-Cell Therapy Product
Table 83. Collectis Revenue in CAR T-Cell Therapy Business (2017-2022) & (US$ Million)
Table 84. Collectis Recent Development
Table 85. Allogene Therapeutics Company Details
Table 86. Allogene Therapeutics Business Overview
Table 87. Allogene Therapeutics CAR T-Cell Therapy Product
Table 88. Allogene Therapeutics Revenue in CAR T-Cell Therapy Business (2017-2022) & (US$ Million)
Table 89. Allogene Therapeutics Recent Development
Table 90. Celyad Company Details
Table 91. Celyad Business Overview
Table 92. Celyad CAR T-Cell Therapy Product
Table 93. Celyad Revenue in CAR T-Cell Therapy Business (2017-2022) & (US$ Million)
Table 94. Celyad Recent Development
Table 95. Research Programs/Design for This Report
Table 96. Key Data Information from Secondary Sources
Table 97. Key Data Information from Primary Sources
List of Figures
Figure 1. CAR T-Cell Therapy Product Picture
Figure 2. Global CAR T-Cell Therapy Market Size, (US$ Million), 2017 VS 2022 VS 2028
Figure 3. Global CAR T-Cell Therapy Market Size 2017-2028 (US$ Million)
Figure 4. United States CAR T-Cell Therapy Market Size, (US$ Million), 2017 VS 2022 VS 2028
Figure 5. United States CAR T-Cell Therapy Market Size 2017-2028 (US$ Million)
Figure 6. United States CAR T-Cell Therapy Market Share in Global 2017-2028
Figure 7. CAR T-Cell Therapy Report Years Considered
Figure 8. Product Picture of Allogeneic
Figure 9. Product Picture of Autologous
Figure 10. Global CAR T-Cell Therapy Market Share by Type in 2022 & 2028
Figure 11. Global CAR T-Cell Therapy Market Size by Type (2017-2028) & (US$ Million)
Figure 12. Global CAR T-Cell Therapy Market Share by Type (2017-2028)
Figure 13. United States CAR T-Cell Therapy Market Share by Type in 2022 & 2028
Figure 14. United States CAR T-Cell Therapy Market Size by Type (2017-2028) & (US$ Million)
Figure 15. United States CAR T-Cell Therapy Market Share by Type (2017-2028)
Figure 16. Product Picture of Hospitals
Figure 17. Product Picture of Cancer Research Centers
Figure 18. Product Picture of Others
Figure 19. Global CAR T-Cell Therapy Market Share by Application in 2022 & 2028
Figure 20. Global CAR T-Cell Therapy Market Size by Application (2017-2028) & (US$ Million)
Figure 21. Global CAR T-Cell Therapy Market Share by Application (2017-2028)
Figure 22. United States CAR T-Cell Therapy Market Share by Application in 2022 & 2028
Figure 23. United States CAR T-Cell Therapy Market Size by Application (2017-2028) & (US$ Million)
Figure 24. United States CAR T-Cell Therapy Market Share by Application (2017-2028)
Figure 25. North America CAR T-Cell Therapy Market Size Growth Rate 2017-2028 (US$ Million)
Figure 26. U.S. CAR T-Cell Therapy Market Size Growth Rate (2017-2028) & (US$ Million)
Figure 27. Canada CAR T-Cell Therapy Market Size Growth Rate (2017-2028) & (US$ Million)
Figure 28. Europe CAR T-Cell Therapy Market Size Growth Rate 2017-2028 (US$ Million)
Figure 29. Germany CAR T-Cell Therapy Market Size Growth Rate (2017-2028) & (US$ Million)
Figure 30. France CAR T-Cell Therapy Market Size Growth Rate (2017-2028) & (US$ Million)
Figure 31. U.K. CAR T-Cell Therapy Market Size Growth Rate (2017-2028) & (US$ Million)
Figure 32. Italy CAR T-Cell Therapy Market Size Growth Rate (2017-2028) & (US$ Million)
Figure 33. Russia CAR T-Cell Therapy Market Size Growth Rate (2017-2028) & (US$ Million)
Figure 34. Asia-Pacific CAR T-Cell Therapy Market Size Growth Rate 2017-2028 (US$ Million)
Figure 35. China CAR T-Cell Therapy Market Size Growth Rate (2017-2028) & (US$ Million)
Figure 36. Japan CAR T-Cell Therapy Market Size Growth Rate (2017-2028) & (US$ Million)
Figure 37. South Korea CAR T-Cell Therapy Market Size Growth Rate (2017-2028) & (US$ Million)
Figure 38. India CAR T-Cell Therapy Market Size Growth Rate (2017-2028) & (US$ Million)
Figure 39. Australia CAR T-Cell Therapy Market Size Growth Rate (2017-2028) & (US$ Million)
Figure 40. Taiwan CAR T-Cell Therapy Market Size Growth Rate (2017-2028) & (US$ Million)
Figure 41. Indonesia CAR T-Cell Therapy Market Size Growth Rate (2017-2028) & (US$ Million)
Figure 42. Thailand CAR T-Cell Therapy Market Size Growth Rate (2017-2028) & (US$ Million)
Figure 43. Malaysia CAR T-Cell Therapy Market Size Growth Rate (2017-2028) & (US$ Million)
Figure 44. Philippines CAR T-Cell Therapy Market Size Growth Rate (2017-2028) & (US$ Million)
Figure 45. Latin America CAR T-Cell Therapy Market Size Growth Rate 2017-2028 (US$ Million)
Figure 46. Mexico CAR T-Cell Therapy Market Size Growth Rate (2017-2028) & (US$ Million)
Figure 47. Brazil CAR T-Cell Therapy Market Size Growth Rate (2017-2028) & (US$ Million)
Figure 48. Argentina CAR T-Cell Therapy Market Size Growth Rate (2017-2028) & (US$ Million)
Figure 49. Middle East & Africa CAR T-Cell Therapy Market Size Growth Rate 2017-2028 (US$ Million)
Figure 50. Turkey CAR T-Cell Therapy Market Size Growth Rate (2017-2028) & (US$ Million)
Figure 51. Saudi Arabia CAR T-Cell Therapy Market Size Growth Rate (2017-2028) & (US$ Million)
Figure 52. U.A.E CAR T-Cell Therapy Market Size Growth Rate (2017-2028) & (US$ Million)
Figure 53. Celgene (Juno Therapeutics) Revenue Growth Rate in CAR T-Cell Therapy Business (2017-2022)
Figure 54. Novartis Revenue Growth Rate in CAR T-Cell Therapy Business (2017-2022)
Figure 55. Gilead (Kite Pharma) Revenue Growth Rate in CAR T-Cell Therapy Business (2017-2022)
Figure 56. Pfizer Revenue Growth Rate in CAR T-Cell Therapy Business (2017-2022)
Figure 57. CARsgen Therapeutics Revenue Growth Rate in CAR T-Cell Therapy Business (2017-2022)
Figure 58. Autolus Therapeutics Revenue Growth Rate in CAR T-Cell Therapy Business (2017-2022)
Figure 59. Aurora BioPharma Revenue Growth Rate in CAR T-Cell Therapy Business (2017-2022)
Figure 60. Sorrento Therapeutics Revenue Growth Rate in CAR T-Cell Therapy Business (2017-2022)
Figure 61. Mustang Bio Revenue Growth Rate in CAR T-Cell Therapy Business (2017-2022)
Figure 62. Bluebird Bio Revenue Growth Rate in CAR T-Cell Therapy Business (2017-2022)
Figure 63. Collectis Revenue Growth Rate in CAR T-Cell Therapy Business (2017-2022)
Figure 64. Allogene Therapeutics Revenue Growth Rate in CAR T-Cell Therapy Business (2017-2022)
Figure 65. Celyad Revenue Growth Rate in CAR T-Cell Therapy Business (2017-2022)
Figure 66. Bottom-up and Top-down Approaches for This Report
Figure 67. Data Triangulation
Figure 68. Key Executives Interviewed
  • Global Nuclear Medicine Cyclotron Systems Market Report, History and Forecast 2018-2029
    Published: 11-Jan-2024        Price: US 3350 Onwards        Pages: 118
    The global Nuclear Medicine Cyclotron Systems market was valued at US$ 220.85 million in 2022 and will reach US$ 283.75 million by the end of 2029, growing at a CAGR of 4.38% during 2023-2029. Asia-Pacific market for Nuclear Medicine Cyclotron Systems was valued at $ 61.16 million in 2022 and will reach $ 104.22 million by 2029, at a CAGR of 5.84% during the forecast period of 2023 through 2029. Report Scope This report aims to provide a comprehensive presentation of the glo......
  • Global Non-imaging Diagnostic Catheter Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 95
    The global Non-imaging Diagnostic Catheter market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estim......
  • Global Imaging Diagnostic Catheter Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 90
    The global Imaging Diagnostic Catheter market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estimated......
  • Global PCR Equipment Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 77
    The global PCR Equipment market was valued at US$ 806 million in 2023 and is anticipated to reach US$ 1230.7 million by 2030, witnessing a CAGR of 6.7% during The forecast period 2024-2030. PCR (Polymerase Chain Reaction) equipment is widely used in molecular biology and genetics research for amplifying DNA and RNA sequences. The market for PCR equipment is influenced by several key drivers. Here are some of The significant market drivers: Advancements in Research and Diagnost......
  • Global Disposable Sterile Syringes and Needles Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 109
    The global Disposable Sterile Syringes and Needles market was valued at US$ 404.4 million in 2023 and is anticipated to reach US$ 539.1 million by 2030, witnessing a CAGR of 2.1% during The forecast period 2024-2030. North American market for Disposable Sterile Syringes and Needles is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Disposable Sterile Syringes and N......
  • Global Orthopaedic Power Tools Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 106
    The global Orthopaedic Power Tools market was valued at US$ 463.3 million in 2023 and is anticipated to reach US$ 746.5 million by 2030, witnessing a CAGR of 7.3% during The forecast period 2024-2030. North American market for Orthopaedic Power Tools is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Orthopaedic Power Tools is estimated to increase from $ million i......
  • Global Cerebrospinal Fluid Management Devices Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 86
    The global Cerebrospinal Fluid Management Devices market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Cerebrospinal Fluid Management Devices is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Cerebrospinal Fluid Management Devices is estimate......
  • Global CAD & CAM Milling Burs Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 79
    The global CAD & CAM Milling Burs market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for CAD & CAM Milling Burs is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for CAD & CAM Milling Burs is estimated to increase from $ million in 2023 to reach $ ......
  • Global Artificial Teeth Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 98
    The global Artificial Teeth market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Artificial Teeth is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Artificial Teeth is estimated to increase from $ million in 2023 to reach $ million by 2030, a......
  • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs